spacer
home > ict > summer 2019 > the service model dichotomy
PUBLICATIONS
International Clinical Trials

The Service Model Dichotomy





In the context of progressive and steady economic growth, sponsors and CROs are continually looking for the right outsourcing models to sustain their portfolios and share complementary expertise for the long term, while ensuring flexibility in the short term. Broadly speaking, outsourcing models adhere to one of the following three approaches:

  • A full-service approach using either an exclusive or dual-vendor strategy
  • Functional approaches using different strategic vendors for different service areas
  • A more ad hoc, preferred vendor approach where competitive bidding continues

While each approach has its pros and cons, the market is quickly shifting to one of dichotomy, where either functional service provision (FSP) or full-service models are the preferred option among trial sponsors.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Daniel Chapple is a Director at Quanticate and oversees a number of functions, including commercial activities. Daniel has over 20 years of experience within the drug development field, with over 15 years spent in the CRO and business process outsourcing sector. He holds a doctorate in Biochemistry, Microbiology, and Immunology from the University of London, UK, is a Fellow of the Institute of Sales Management (FISM), and is a certified ‘green belt’ in Lean Six Sigma.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Cargo Convoy Departs to China Carrying Medical Supplies Donated by Qatar Airways for Coronavirus Relief

2,500,000 face masks and 500,000 bottles of hand sanitizer have been donated by Qatar Airways
More info >>

White Papers

Clinical Trial Disclosure Management: Build vs. Buy

TrialScope

Because software development is our core competency, TrialScope continues to make a significant investment in our technology. We employ agile methodologies to ensure that we can maintain a continuing level of responsiveness as disclosure requirements evolve across registries and regions.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement